Back to search
FDAFDA · Food and drugs·Recall number D-0009-2019

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

Published October 10, 2018 · Recall initiated: September 17, 2018

Summary

FDA records drug Class I recall D-0009-2019, published October 10, 2018 and initiated September 17, 2018. Recalling firm: Endo Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 2,856 bottles; Lot: Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Endo Pharmaceuticals, Inc.
Distributor
Nationwide in the USA.
Lot
Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10. recalled?

Yes. FDA published recall D-0009-2019 on October 10, 2018. Reported hazard: Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

What should I do if I have this product?

Voluntary: Firm initiated · Letter